Carolyn Myers Ph.D. was appointed President-Elect of Dey L.P. Mylan’s specialty pharmaceutical division in October 2007. Dr. Myers also serves as President of Mylan Technologies Inc. (MTI) a position she has held since February 2006. While at MTI Dr. Myers has overseen the design development and manufacture of Mylan’s transdermal drug delivery system. She first joined Mylan in 2003 as Vice President of Branded Business Development and Strategic Marketing. Prior to joining Mylan Dr. Myers served as Global Director Cardiovascular at Pharmacia Inc.
|